Business
Press Release Mar 27 2023
Lupin Limited has informed the Exchange regarding a press release dated March 27, 2023, titled "Lupin Receives Tentative Approval from U.S. FDA for Valbenazine Capsules.".
About this update from Lupin Limited
[{"type":"text","content":" Lupin Limited has informed the Exchange regarding a press release dated March 27, 2023, titled \"Lupin Receives Tentative Approval from U.S. FDA for Valbenazine Capsules.\". View Attachment","length":339,"tagName":"div"}]